DNMT3A and postmenopausal osteoporosis: Studies show that osteocyte ferroptosis, regulated by the Nrf2 pathway, affects RANKL expression via Dnmt3a-mediated DNA methylation of the RANKL promoter, influencing OC formation and contributing to postmenopausal osteoporosis (PMOP) (81).